Medeta has been selected for the AMED Digital Healthcare Development and Implementation Acceleration Program (FY2024, 2nd Call).

Our adopted research theme is:

“Development of a SaMD for Euploid Embryo Screening Based on Machine Learning and Evaluation of Its Economic Impact.”

AMED, Japan’s core national agency for medical research and innovation, plays a central role in bridging scientific discovery to clinical application. With this support, Medeta will further accelerate collaboration with medical and research institutions to advance SaMD development and societal implementation.

Program Details:
https://www.amed.go.jp/koubo/12/01/1201C_00146.html